Showing results (121-130 of 419) with videos related to
Sort By:
Pageof 42
Molecular Cancer Therapeutics|April 12, 2022
Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600-Mutant TumorsJacob J Adashek, Arjun K Menta, Neha K Reddy, et al.Oncoscience|September 22, 2023
Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcomaMohamed A Gouda, Maria A Zarzour, Ara A Vaporciyan, et al.Oncotarget|January 8, 2014
A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin's lymphomaVivek Subbiah, Robert E Brown, Mary F McGuire, et al.The Journal of Craniofacial Surgery|July 23, 2026
Factor V Leiden in Head and Neck Reconstruction: Institutional Experience and ProtocolAdwight Risbud, Alexander Fish, Kevin S Scher, et al.Molecular Cancer Therapeutics|September 8, 2021
Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant CancersJacob J Adashek, Aakash P Desai, Alexander Y Andreev-Drakhlin, et al.Plos One|August 8, 2013
Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1)Vivek Subbiah, Robert E Brown, Yunyun Jiang, et al.Thyroid Research|August 13, 2023
Challenges in the care of patients with RET-altered thyroid cancer: a multicountry mixed-methods studySuzanne Murray, Vivek Subbiah, Steven I Sherman, et al.Med (New York, N.Y.)|January 29, 2026
Precision oncology in rare tumors: Have the orphans been adopted?Hiba Mechahougui, Alex Friedlaender, Kıvanç Görgülü, et al.Journal of Hematology & Oncology|August 28, 2022
Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional responseHanna E Persha, Shumei Kato, Pradip De, et al.Cutis|June 25, 2019
Vandetanib photoinduced cutaneous toxicitiesHung Q Doan, Mimi I Hu, Jennifer Goldstein, et al.Pageof 42